| Moderna's vaccine for kids ages 6-11 shows a "robust" immune response in a study of more than 4,500 youths, the company said Tuesday. Moderna said it plans to submit the data to the U.S. Food and Drug Administration "in the near term." The study involved a two-dose vaccine with a dosage about half that of the adult vaccine. | | News Alert Monday, October 25 | | | | | | | | | | | |
No comments:
Post a Comment